FDA webinar Oct. 31 on proposed rule for laboratory developed tests 

Oct 18, 2023 - 02:16 PM
Cybersecurity woman IT professional

On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests, which would amend the agency’s regulations to require most laboratory developed tests to meet the same medical device requirements as other in vitro diagnostic products. Participants may email questions for consideration to CDRHWebinars@fda.hhs.gov until Oct. 23.

Related News Articles

Headline
FDA finalizes recommendations simplifying approval process for medical devices that use AI
FDA finalizes recommendations simplifying approval process for medical devices that use AI The Food and Drug Administration yesterday released…
Headline
HHS says impacts to medical products should be limited as strike at U.S. ports begins
The Department of Health and Human Services Sept. 30 released a statement on the dockworker strike at ports along the East and Gulf coasts, saying that…
Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
GAO recommends FDA, CISA update medical device security documentation based on AHA input
The Government Accountability Office Dec. 21 recommended the Food and Drug Administration and Cybersecurity and Infrastructure and Security Agency update a 5-…
Headline
Report offers ways to address cybersecurity challenges posed by legacy medical devices 
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device…
Headline
FDA approves first sterilization system for 3D-printed medical devices
The Food and Drug Administration the week of Aug. 7 cleared for marketing the first sterilization system for 3D-printed devices in health care facilities. The…